Accordingly, DAB2IP expression is positively associated with improved prognosis of colon cancer in patients with wild-type p53 tumors, in line with the notion that DAB2IP could support the tumor-suppressive action of p53 [13]. Here, DAB2IP is linked to malignant colon neoplasm.